# Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis

> **NCT03843385** · PHASE3 · RECRUITING · sponsor: **Andreas Stallmach** · enrollment: 129 (estimated)

## Conditions studied

- Ulcerative Colitis
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** encapsulated faecal microbiota filtrate
- **DRUG:** encapsulated faecal microbiota
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03843385
- **Lead sponsor:** Andreas Stallmach
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-31
- **Primary completion:** 2026-07
- **Final completion:** 2027-04
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03843385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03843385, "Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03843385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*